Ultima PharmaHexarelin 2 mg
| Quantity | Discount | Price |
|---|---|---|
| 3–5 | 10% | $49,50 |
| 6–9 | 15% | $46,75 |
| 10–100 | 20% | $44,00 |
Specifications
- Brand: Ultima Pharma Peptides & SARMs
- Substance: Hexarelin
- Product Form: Powder
- Dosage: 2 mg
How To Use
Laboratory Reconstitution & Research Dosing Protocols
Disclaimer: The following information is for educational and laboratory reference only. This product is strictly for in-vitro and in-vivo research and is not intended for human consumption or therapeutic use.
This vial contains 2 mg (2,000 mcg) of lyophilized Hexarelin powder. Due to its high potency and potential for receptor desensitization, precise timing is essential for maintaining analytical accuracy.
Reconstitution Guide
For standard research concentration, reconstitute the 2 mg vial with 1 ml of Bacteriostatic Water or Sterile Saline.
- Preparation: Slowly inject 1 ml of water against the glass wall of the vial.
- Dissolution: Swirl gently until clear. Do not shake, as the peptide structure is sensitive to mechanical stress.
- Measurement Reference (Using 1 ml dilution):
- 5 Units (0.05 ml) = 100 mcg
- 10 Units (0.10 ml) = 200 mcg
- 20 Units (0.20 ml) = 400 mcg
Storage Specifications
- Unmixed (Lyophilized): Store in a cool, dry place. For long-term preservation, store at -20°C.
- Mixed (Reconstituted): Must be refrigerated (2°C to 8°C). Use within 14 days for maximum analytical integrity.
Experience Level Usage Guide
Beginner
Baseline Cardioprotective Model
Reference dosing for initial studies investigating cardiac cell resilience and baseline GH spikes.
- Test Subject Dosage: 100 mcg per administration.
- Frequency: Administered once daily (Typically prior to the subject's rest cycle).
- Observation Period: 2 to 4 weeks.
Intermediate
Intensive Recovery Model
Standard dosage for evaluating rapid tissue repair and maximum endogenous IGF-1 upregulation.
- Test Subject Dosage: 200 mcg per administration.
- Frequency: Administered twice daily (Split 12 hours apart).
- Observation Period: 4 to 6 weeks.
Advanced
Advanced Somatotropic Synergy Stack
Advanced protocol investigating the synergy between GHS and GHRH analogs for maximum growth signaling.
- The Stack: Hexarelin (200 mcg) + CJC-1295 no DAC (100 mcg).
- Scientific Rationale: Investigates the synergy between the potent ghrelin-receptor agonism of Hexarelin and the direct GHRH receptor activation of CJC-1295 to achieve the theoretical maximum GH pulse.
- Frequency: Combined administration 2 times daily for acute longitudinal research.
Shipping Details
Detailed Description
What Is Ultima Pharma Hexarelin 2 mg?
Ultima Pharma Hexarelin 2 mg is a potent synthetic hexapeptide and a highly selective growth hormone secretagogue (GHS). Within the scientific community, it is recognized as one of the most powerful analogs in the GHRP family, researched for its ability to induce rapid and significant growth hormone pulses. This 2 mg lyophilized vial is a foundational tool for USA domestic research facilities investigating pituitary response, cardiovascular tissue repair, and the mechanisms of systemic musculoskeletal regeneration.
If your research goals involve exploring the limits of endocrine signaling or the recovery of cardiac tissue following oxidative stress, you can buy peptides of this analytical grade through our Muscle Growth Peptides & SARMs category.
Important: Ultima Pharma Hexarelin 2 mg is strictly for laboratory research and is not intended for human consumption or therapeutic use.
Ultima Pharma Hexarelin 2 mg: Technical Profile
| Scientific Parameter | Details for Ultima Pharma Hexarelin |
|---|---|
| Peptide Type | GHRP (Growth Hormone Releasing Peptide) |
| Vial Concentration | 2 mg Lyophilized Powder |
| Purity Level | >99% (HPLC Verified) |
| Primary Focus | Acute GH Secretion & Myocardial Support |
Research Benefits of Ultima Pharma Hexarelin 2 mg
In controlled laboratory settings, it is valued for its superior potency compared to other secretagogues. Key research benefits include:
- Peak GH Pulsatility: Studying how Hexarelin triggers the highest observed growth hormone spikes among the GHRP class in research subjects.
- Cardioprotective Signaling: Investigating the peptide’s ability to bind to the CD36 receptor to protect heart tissue and potentially improve cardiac output.
- Skeletal System Maintenance: Researching the peptide’s role in improving bone mineral density and preventing muscle atrophy in wasting models.
- Tissue Synergy: Exploring how Peptidesline’s Hexarelin interacts with IGF-1 LR3 to maximize systemic repair and nitrogen retention.
How Does Ultima Pharma Hexarelin 2 mg Work?
The mechanism of involves the activation of the ghrelin/growth hormone secretagogue receptor (GHS-R1a) in the pituitary gland. Unlike Ipamorelin, Hexarelin also has a secondary affinity for cardiovascular receptors, specifically the CD36 receptor. This dual-action pathway makes it a primary focus for studies on both endocrine pulses and heart health. Because Peptidesline provides vacuum-sealed, analytical-grade Ultima Pharma products, researchers can reliably track these intense biological shifts with high experimental precision.
Potential Side Effects in Research Models
Due to its high potency, researchers utilizing must monitor for dose-dependent responses in laboratory subjects:
- Receptor Desensitization: Studies note that the pituitary can desensitize to Hexarelin faster than other GHRPs during long-term research.
- Hormonal Variance: Potential observed effects include temporary increases in cortisol and prolactin markers during high-dose protocols.
- Dermal Sensitivity: Potential localized redness or mild itching at the administration site.
- Lethargy Signals: Researchers frequently monitor for signs of increased tiredness following the massive GH pulse.
Hexarelin vs. Alternative Growth Peptides
| Research Peptide | Receptor Pathway | Primary Research Strength |
|---|---|---|
| Ipamorelin | Selective GHS-R1a | Stable GH pulse with minimal ancillary hormone impact. |
| GHRP-2 | Non-Selective GHS-R1a | High GH yield with moderate hunger induction. |
| CJC-1295 | GHRH Receptor | Extended baseline growth hormone secretion. |
| Hexarelin 2 mg | GHS-R1a & CD36 | Superior GH spike and cardiovascular support. |
Buy Ultima Pharma Hexarelin 2 mg Online
When conducting critical cardiovascular or endocrine repair assays, Peptidesline is your reliable source for batch-certified compounds. Our Hexarelin is vacuum-sealed and HPLC-verified for 100% integrity.
- Express USA Delivery: Fast shipping to your research facility in 4-7 business days.
- Secure Checkout: Simple payment options via Zelle or Venmo.
- 10% Crypto Discount: Unlock a 10% discount on Hexarelin 2 mg by paying with Bitcoin or USDT.
- Click here for Payment Options
FAQ
Hexarelin is distinct because it is the only GHRP researched for its direct affinity to the CD36 receptor, making it a primary focus for studies on heart tissue protection.
In research environments, Hexarelin has been observed to produce a significantly higher peak GH pulse compared to Ipamorelin or GHRP-2 at identical concentrations.
Hexarelin has a relatively short half-life of approximately 60-70 minutes, which provides a concise window for studying high-intensity hormonal pulses.
Yes, its ability to acutely raise IGF-1 levels makes it a valuable tool on Peptidesline for investigating the rapid repair of tendons, ligaments, and bone density.
Yes, studies indicate that receptors may desensitize to Hexarelin faster than other secretagogues, so researchers often study its effects in short-duration longitudinal models.
